TCL Archive FDA Committee Okays Leuprolide NDA, But Recommends Against Mitoxantrne, Epirubicin April 5, 1985
TCL Archive EntreMed Begins Pilot Phase II Trial Of Small Molecule Angiogenesis Inhibitor. December 15, 2000
TCL Archive NCI Doesn’t Indicate Willingness To Review Large Programs As BSA Recommends. “We’re Celebrating Success,” NCI Director von Eschenbach Says. Intramural Program Isn’t Delivering What It Should, Margaret Tempero Says. March 31, 2006
